Jazz Pharmaceuticals, Inc. (JAZZ) Tops Q1 EPS by 2c; Guides Above the Street
Tweet Send to a Friend
Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ) reported Q1 EPS of $1.37, $0.02 better than the analyst estimate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
